Skip to main content Skip to main navigation menu Skip to site footer
  • Register
  • Login
  • Menu
  • Home
  • Current
  • Archives
  • Announcements
  • About
    • About the Journal
    • Submissions
    • Editorial Team
    • Privacy Statement
    • Contact
  • Register
  • Login

Journal of Education, Health and Sport

Standard and innovative options in the treatment of insulin resistance
  • Home
  • /
  • Standard and innovative options in the treatment of insulin resistance
  1. Home /
  2. Archives /
  3. Vol. 12 No. 8 (2022) /
  4. Review Articles

Standard and innovative options in the treatment of insulin resistance

Authors

  • Jakub Metelski Wojewódzki Szpital Specjalistyczny im. Stefana Kardynała Wyszyńskiego Samodzielny Publiczny Zakład Opieki Zdrowotnej w Lublinie https://orcid.org/0000-0002-7110-9332
  • Katarzyna Krauze-Kuc Provincial Specialist Hospital in Zgierz https://orcid.org/0000-0001-5896-0627
  • Aleksandra Metelska Provincial Specialist Hospital of the name Stefan Cardinal Wyszyński, Aleja Kraśnicka 100, 20-718 Lublin https://orcid.org/0000-0002-3166-1296
  • Dominika Sereda Independent Public Clinical Hospital No. 4 in Lublin, Jaczewskiego 8, 20-954 Lublin https://orcid.org/0000-0003-4189-1674
  • Hubert Nieścior Medical University of Lublin, Aleje Racławickie 1, 20-059 Lublin https://orcid.org/0000-0002-4709-4396

DOI:

https://doi.org/10.12775/JEHS.2022.12.08.041

Keywords

insulin resistance, treatment, FGF-21, metformin, SGLT-2 inhibitors

Abstract

Introduction and purpose 

Insulin resistance is a state of decreased tissue sensitivity to insulin, despite normal or elevated levels of this hormone in the blood serum. People with insulin resistance for a long time do not show symptoms, which makes it particularly difficult to detect and treat in early stages. It mainly leads to impaired glucose homeostasis and the development of type 2 diabetes, which contributes to the exacerbation of the global problem that diabetes has become. This results in the search for innovative therapies that will help combat insulin resistance better and better. The purpose of this study is to highlight the complexity of the IR and review the current literature for non-pharmacological and pharmacological possibilities of treatment  for insulin resistance. 

Description of the state of knowledge 

Due to the increase in obesity and the metabolic syndrome, the number of people suffering from insulin resistance is constantly increasing.  In modern times, there are various diagnostic and therapeutic methods that affect the course of insulin resistance. Early detection and introduction of appropriate therapy become the main goal in preventing complications that may occur in the course of this disease.

 

Summary

Treatment methods for insulin resistance can be divided into two groups - non-pharmacological and pharmacological. Both of them are often used together in the form of combination therapy aimed at obtaining the best results in the treatment of insulin resistance. For people for whom known therapies do not work, researches for new treatments is becoming a hope.

References

Freeman AM, Pennings N (2021). Insulin Resistance - StatPearls - NCBI Bookshelf. StatPearls Publishing, Treasure Island (FL). https://www.ncbi.nlm.nih.gov/books/NBK507839/

Sampath Kumar A, Maiya AG, Shastry BA, Vaishali K, Ravishankar N, Hazari A, Gundmi S, Jadhav R (2019). Exercise and insulin resistance in type 2 diabetes mellitus: A systematic review and meta-analysis. Annals of Physical and Rehabilitation Medicine, 62(2), 98–103. https://doi.org/10.1016/j.rehab.2018.11.001

Fahed M, Abou Jaoudeh MG, Merhi S, Mosleh JMB, Ghadieh R, Al Hayek, Al Hayek S, El Hayek Fares JE (2020). Evaluation of risk factors for insulin resistance: A cross sectional study among employees at a private university in Lebanon. BMC Endocrine Disorders, 20(1), 1–14. https://doi.org/10.1186/s12902-020-00558-9

Placzkowska S, Pawlik-Sobecka L, Kokot I, Piwowar A (2019). Indirect insulin resistance detection: Current clinical trends and laboratory limitations. Biomedical Papers, 163(3), 187–199. https://doi.org/10.5507/bp.2019.021

Soumya D, Srilatha B (2011). Late Stage Complications of Diabetes and Insulin Resistance. Journal of Diabetes & Metabolism, 02(09), 1–7. https://doi.org/10.4172/2155-6156.1000167

Suliburska J, Uśnierek J (2010). Czynniki żywieniowe i pozażywieniowe w rozwoju insulinooporności. Forum Zaburzeń Metabolicznych, 1(3), 177–183. Polish.

Pasek I, Wiska L, Kopytko P, Banach B (2021). Methods of treatment of obesity in patients with type 2 diabetes. Farmacja Polska, 77(7), 442–450. https://doi.org/10.32383/farmpol/142112 . Polish.

Strojek K, Wróbel M, Szymborska-Kajanek A, Rokicka D (2013). Metformina - Nowe wskazania refundacyjne. Diabetologia Kliniczna, 2(4), 120–124.

Saluja M, Pareek KK, Swami YK (2020). Study of Diversity of Metformin Related Gastrointestinal Side Effects. The Journal of the Association of Physicians of India, 68(8), 36–38. http://europepmc.org/abstract/MED/32738838

Flory J, Lipska K (2019). Metfonim in 2019. Jama, 321(19), 1926–1927. https://doi.org/10.1001/jama.2019.3805.Metformin

Knudsen LB, Lau J (2019). The discovery and development of liraglutide and semaglutide. Frontiers in Endocrinology, 10 (APR). https://doi.org/10.3389/fendo.2019.00155

Pegah A, Abbasi-Oshaghi E, Khodadadi I, Mirzaei F, Tayebinia H (2021). Probiotic and resveratrol normalize GLP-1 levels and oxidative stress in the intestine of diabetic rats. Metabolism Open, 10, 100093. https://doi.org/10.1016/j.metop.2021.100093

Wharton S, Davies M, Dicker D, Lingvay I, Mosenzon O, Rubino DM, Pedersen SD (2022). Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practice. Postgraduate Medicine, 134(1), 14–19. https://doi.org/10.1080/00325481.2021.2002616

Lebovitz HE (2019). Thiazolidinediones: the Forgotten Diabetes Medications. Current Diabetes Reports, 19(12), 1–13. https://doi.org/10.1007/s11892-019-1270-y

Karbowiak P, Rzeszotarski J, Walasek L (2013). Inhibitory kotransportera glukozowo- doustnych leków przeciwcukrzycowych. 191–197.

Xu L, Ota T (2018). Emerging roles of SGLT2 inhibitors in obesity and insulin resistance: Focus on fat browning and macrophage polarization. Adipocyte, 7(2), 121–128. https://doi.org/10.1080/21623945.2017.1413516

Verma S, McMurray JJV (2018). SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review. Diabetologia, 61(10), 2108–2117. https://doi.org/10.1007/s00125-018-4670-7

Jasik M (2010). Inhibitory dipeptydylopeptydazy 4 ( DPP-4 ) ze szczególnym uwzględnieniem sitagliptyny. Wybrane Problemy Kliniczne, 1(4), 220–229

Ghorbani Y, Schwenger KJP, Allard JP (2021). Manipulation of intestinal microbiome as potential treatment for insulin resistance and type 2 diabetes. European Journal of Nutrition, 60(5), 2361–2379. https://doi.org/10.1007/s00394-021-02520-4

Soleimani A, Zarrati Mojarrad M, Bahmani F, Taghizadeh M, Ramezani M, Tajabadi-Ebrahimi M, Jafari P, Esmaillzadeh A, Asemi Z (2017). Probiotic supplementation in diabetic hemodialysis patients has beneficial metabolic effects. Kidney International, 91(2), 435–442. https://doi.org/10.1016/j.kint.2016.09.040

Doron S, Snydman DR (2015). Risk and safety of probiotics. Clinical Infectious Diseases, 60(Suppl 2), S129–S134. https://doi.org/10.1093/cid/civ085

Wang W, Zhang J, Wang H, Wang X, Liu S (2019). Vitamin D deficiency enhances insulin resistance by promoting inflammation in type 2 diabetes. International Journal of Clinical and Experimental Pathology, 12(5), 1859–1867. http://www.ncbi.nlm.nih.gov/pubmed/31934009%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC6947100

Abbasi Oshaghi E, Goodarzi MT, Higgins V, Adeli K (2017). Role of resveratrol in the management of insulin resistance and related conditions: Mechanism of action. Critical Reviews in Clinical Laboratory Sciences, 54(4), 267–293. https://doi.org/10.1080/10408363.2017.1343274

Jimenez V, Jambrina C, Casana E, Sacristan V, Muñoz S, Darriba S, Rodó J, Mallol C, Garcia M, León X, Marcó S, Ribera A, Elias I, Casellas A, Grass I, Elias G, Ferré T, Motas S, Franckhauser S, Mulero F, Navarro M, Haurigot V, Ruberte J, Bosch F (2018). FGF21 gene therapy as treatment for obesity and insulin resistance. EMBO Molecular Medicine, 10(8), 1–24. https://doi.org/10.15252/emmm.201708791

Downloads

  • PDF

Published

2022-08-10

How to Cite

1.
METELSKI, Jakub, KRAUZE-KUC, Katarzyna, METELSKA, Aleksandra, SEREDA, Dominika & NIEŚCIOR, Hubert. Standard and innovative options in the treatment of insulin resistance. Journal of Education, Health and Sport [online]. 10 August 2022, T. 12, nr 8, s. 393–406. [accessed 27.3.2023]. DOI 10.12775/JEHS.2022.12.08.041.
  • PN-ISO 690 (Polish)
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
Download Citation
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

Issue

Vol. 12 No. 8 (2022)

Section

Review Articles

License

Copyright (c) 2022 Jakub Metelski, Katarzyna Krauze-Kuc, Aleksandra Metelska, Dominika Sereda, Hubert Nieścior

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0

Stats

Number of views and downloads: 128
Number of citations: 0

Search

Search

Browse

  • Browse Author Index
  • Issue archive

User

User

Current Issue

  • Atom logo
  • RSS2 logo
  • RSS1 logo

Information

  • For Readers
  • For Authors
  • For Librarians

Newsletter

Subscribe Unsubscribe

Tags

Search using one of provided tags:

insulin resistance, treatment, FGF-21, metformin, SGLT-2 inhibitors
Up

Akademicka Platforma Czasopism

Najlepsze czasopisma naukowe i akademickie w jednym miejscu

apcz.umk.pl

Partners

  • Akademia Ignatianum w Krakowie
  • Akademickie Towarzystwo Andragogiczne
  • Fundacja Copernicus na rzecz Rozwoju Badań Naukowych
  • Instytut Historii im. Tadeusza Manteuffla Polskiej Akademii Nauk
  • Instytut Kultur Śródziemnomorskich i Orientalnych PAN
  • Karmelitański Instytut Duchowości w Krakowie
  • Państwowa Akademia Nauk Stosowanych w Krośnie
  • Państwowa Akademia Nauk Stosowanych we Włocławku
  • Państwowa Wyższa Szkoła Zawodowa im. Stanisława Pigonia w Krośnie
  • Polskie Towarzystwo Ekonomiczne
  • Polskie Towarzystwo Ludoznawcze
  • Towarzystwo Miłośników Torunia
  • Towarzystwo Naukowe w Toruniu
  • Uniwersytet im. Adama Mickiewicza w Poznaniu
  • Uniwersytet Mikołaja Kopernika
  • Uniwersytet w Białymstoku
  • Uniwersytet Warszawski
  • Wojewódzka Biblioteka Publiczna - Książnica Kopernikańska
  • Wyższe Seminarium Duchowne w Pelplinie / Wydawnictwo Diecezjalne „Bernardinum" w Pelplinie

© 2021- Nicolaus Copernicus University Accessibility statement Shop